Table 2_Harnessing mRNA technology against Fasciola hepatica: Immunological insights from a fatty acid binding protein vaccine.docx
<p>mRNA platforms offer a promising strategy to overcome limitations in helminth vaccinology. We used the helminth Fasciola hepatica, which is a major veterinary and zoonotic pathogen for which no licensed vaccine exists, as a test case. We engineered a codon-optimized mRNA encoding the F. hep...
שמור ב:
| מחבר ראשי: | |
|---|---|
| מחברים אחרים: | , , , , , , , , , , |
| יצא לאור: |
2025
|
| נושאים: | |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|